Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy

Immunotherapy

Novel immunotherapy strategies for hepatobiliary cancers

Immunotherapy.

DeLeon TT, Zhou Y, Nagalo BM, Yokoda RT, Ahn DH, Ramanathan RK, Salomao MA, Aqel BA, Mahipal A, Bekaii-Saab TS, Borad MJ

doi: 10.2217/imt-2018-0024.

ImmunotherapyT Cells

Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers

Clin Sci (Lond).

Inthagard J, Edwards J, Roseweir AK

doi: 10.1042/CS20181003.

RECOMMENDED

Immunotherapy

Development of a novel class of interleukin-2 immunotherapies for metastatic cancer

doi: smw.2019.14697.

Melanoma and Skin Cancer

Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis

Int Immunopharmacol.

Caisová V, Uher O, Nedbalová P, Jochmanová I, Kvardová K, Masáková K, Krejčová G, Paďouková L, Chmelař J, Kopecký J, Ženka J

doi: 10.1016/

Immunotherapy

Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics

Nanomedicine (Lond).

Grimaldi AM, Incoronato M, Salvatore M, Soricelli A

doi: 10.2217/nnm-2017-0208.

Immunotherapy

Immunotherapy in Gastrointestinal Cancers

Biomed Res Int.

Procaccio L, Schirripa M, Fassan M, Vecchione L, Bergamo F, Prete AA, Intini R, Manai C, Dadduzio V, Boscolo A, Zagonel V, Lonardi S

doi: 10.1155/2017/4346576.

Melanoma and Skin CancerImmunotherapy

Identification of essential genes for cancer immunotherapy

Nature.

Patel SJ, Sanjana NE, Kishton RJ, Eidizadeh A, Vodnala SK, Cam M, Gartner JJ, Jia L, Steinberg SM, Yamamoto TN, Merchant AS, Mehta GU, Chichura A, Shalem O, Tran E, Eil R, Sukumar M, Guijarro EP, Day CP, Robbins P, Feldman S, Merlino G, Zhang F, Restifo NP

doi: 10.1038/nature23477.

Immunotherapy

Metabolic Checkpoints: Novel Avenues for Immunotherapy of Cancer

Front Immunol.

Shevchenko I, Bazhin AV

doi: 10.3389/fimmu.2018.01816.

Critical features and challenges associated with imaging in patients undergoing cancer immunotherapy

Crit Rev Oncol Hematol.

Solinas C, Porcu M, Hlavata Z, De Silva P, Puzzoni M, Willard-Gallo K, Scartozzi M, Saba L

doi: 10.1016/

Related content

Novel immunotherapy strategies for hepatobiliary cancers

Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers

Development of a novel class of interleukin-2 immunotherapies for metastatic cancer

Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis

Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics

Immunotherapy in Gastrointestinal Cancers

Identification of essential genes for cancer immunotherapy

Metabolic Checkpoints: Novel Avenues for Immunotherapy of Cancer

Critical features and challenges associated with imaging in patients undergoing cancer immunotherapy